Skip to main content
. Author manuscript; available in PMC: 2014 Jun 27.
Published in final edited form as: J Med Chem. 2013 Jun 13;56(12):5059–5070. doi: 10.1021/jm400369q

Table 1.

Inhibition of human α-thrombin by sulfated benzofurans.a

logIC50 IC50 (μM) HS ΔYa (%)
9a −6.17 ± 0.03 0.67 ± 0.04b 1.5 ± 0.2 79 ± 9
9b −5.69 ± 0.13 2.0 ± 0.6 1.0c 39 ± 2
9c −3.78 ± 0.07 165 ± 25 2.1 ± 0.5 ~94d
9d >500 NAe NA
9f −5.23 ± 0.11 5.8 ± 1.5 2.3 ± 1.2 43 ± 3
9g ~ −4.0d ~ 99d UDf ~ 26d
12 >500 NA NA
13 −4.51 ± 0.06 31 ± 4 3.5 ± 1.2 53 ± 4
14 −4.18 ± 0.17 66 ± 25 1.0c 49 ± 5
17 −3.80 ± 0.15 158 ± 55 1.0c 62 ± 16
23 −3.81 ± 0.13 154 ± 45 1.2 ± 0.3 ~ 91d
a

Logistic equation 1 was used to fit the dose-dependence of the residual thrombin activity to obtain logIC50, HS, Y0, and YM values for inhibition in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl2, and 0.1% PEG8000 at 25 °C (see ‘Experimental Procedures’). ΔY = YM − Y0.

b

Errors represent ± 1 S. E.

c

HS was fixed to 1.0 to define the inhibition parameters better.

d

Approximate value because either HS, YM or Y0 was not defined well.

e

Not applicable.

f

Undefined.